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Abstract. In this report we demonstrate an increase in 
the steady-state level of bone sialoprotein (BSP) 
mRNA in rat calvaria and a  rat osteosarcoma cell line 
(ROS  17/2.8)  after treatment with the synthetic gluco- 
corticoid, dexamethasone.  In contrast,  1.25- 
dthydroxyvitamin D3 reduced the amount of BSP 
mRNA in calvaria and inhibited the dexamethasone in- 
duction in ROS  17/2.8 cells. The increase in BSP 
mRNA is most likely due to an increase in the tran- 
scriptional  rate.  The stability of mRNA was unchanged 
after dexamethasone treatment with a half-life  of r~5 h. 
Nuclear transcription  experiments with nuclei isolated 
from ROS  17/2.8 cells showed an increased BSP 
mRNA synthesis in cells treated with dexamethasone. 
ONE sialoprotein  (BSP), ~  which we previously called 
sialoprotein  II,  is an acidic glycoprotein associated 
with the mineral matrix in bone and teeth (2, 3). The 
protein contains  ",,50% carbohydrate of which 15 % is sialic 
acid (3). Furthermore, some 30% of the serine residues are 
phosphorylated and contribute to the acidity of BSP. The 
amino acid sequence of BSP, deduced from eDNA, predicts 
a 34-kD protein core with predominantly glutamic acid and 
glycine residues, which constitute one third of all amino acid 
residues (10). The protein contains  several clusters  of up to 
10  consecutive  glutamic  acid  residues.  These  negatively 
charged domains, together with the sialic acid residues and 
phosphate groups, are presumably responsible for the strong 
interaction  with hydroxyapatite. 
BSP promotes the attachment  and spreading  of rat osteo- 
sarcoma cells (ROS 17/12.8) as well as primary bovine chon- 
drocytes in  cell-binding  experiments  using  plastic  dishes 
coated with the protein (11, 12). This cell binding  is appar- 
ently mediated by an RGD-containing  region in BSP, which 
is homologous to the cell-binding domain in vitronectin  (10). 
The BSP receptor is an integrin  indistinguishable  from the 
vitronectin  receptor on the surface of ROS 17/2.8 cells (11). 
BSP shares  some structural  features  with another bone 
protein, osteopontin (OPN) (9). The OPN sequence contains 
a stretch of nine consecutive aspartic acid residues compara- 
ble to the glutamic  acid clusters in BSP. OPN also contains 
a cell-binding  RGD sequence which promotes attachment of 
cells in a similar way as BSP (9).  The synthesis of OPN in 
bone cells is regulated by steroid hormones. It has been shown 
that  1,25-dihydroxyvitamin D3 (vit D3) increases the level of 
OPN mRNA, whereas the synthetic glucocorticoid, dexameth- 
asone, reduces the steady-state  level of OPN mRNA (15). 
It  is  well  established  that  steroid  hormones  have  pro- 
nounced influence on the metabolism of bone. Some of these 
1.  Abbre~ations  used in  this paper:  BSP,  bone siaioprotein; DRB,  5,6- 
dichloro-1-/~-ribofuranosyl  benzimidazole; OPN, osteopontin; ROS, rat os- 
teosarcoma; vit D3,  1,25-dihydroxyvitamin D3. 
effects may be exerted via effects on cells, possibly mediated 
via cell-binding  proteins.  The present study, therefore,  was 
undertaken  to determine the effects of different steroid hor- 
mones on the biosynthesis of two major cell-binding  bone 
proteins. 
Materials and Methods 
Cell and Iissue Cultures 
Calvaria tissue was dissected from neonatal (3-4-d-old) rats.  Isolated cal- 
varia and the rat osteosarcoma cell line ROS 17/2.8 (6), respectively, were 
cultured in Ham's F12 medium (Gibco Laboratories, Grand Island, NY) 
supplemented with 10%  FCS. Dexamethasone (Sigma Chemical Co., St. 
Louis, MO) and vit D3 (a gift from Sandoz, A. G., Basel) were added to 
culture media supplemented with 2% FCS. Both steroids were used at 10  -s M 
in  all  experiments. 5,6-Dichloro-1-/~-ribofuranosyl  benzimidazole (DRB) 
(Sigma Chemical Co., St. Louis, MO), a potent inhibitor of RNA polymer- 
ase II (16),  was used at a concentration of 10  -4 M. 
Isolation and Analysis of  RNA 
RNA was isolated by extraction with guanidine isothiocyanate and centrifu- 
gation in a cesium chloride gradient (7).  Electrophoresis and transfer of 
RNA to nitrocellulose were performed as previously described (9).  The 
filters were hybridized with an OPN eDNA probe as described (9). The BSP 
eDNA probe represented a 446-bp Eco RI-PVU II fragment (nucleotide 
1-446 in reference 10). Filters were hybridized with the BSP probe at 47°C 
in a hybridization solution containing 50% formamide (9). The filters were 
washed with 2  x  SSC (1  x  SSC is 0.15 M NaCi, 0.015 M sodium citrate, 
pH 7.0) at room temperature for I h and finally in 0.2 × SSC at 68°C for I h. 
In Vitro Transcription Analysis 
Nuclei were isolated from ROS 17/2.8 cells (3a) and transcribed in vitro (5) 
using the modifications described by J~ick and Wabl (4). 32p-labeled  RNA 
(2  ×  108 cpm/ml) was hybridized to nitrocellulose filters carrying single- 
stranded BSP or OPN cDNA.  An Eco RI-Pvu II fragment (nucleotide 
1-446 in reference 10) was ligated to MI3 mpl8 and mpl9 in sense and an- 
tisense orientation. Also an Eco RI fragment of hROPI (9) was ligated to 
MI3  in  both orientations.  Single-stranded MI3  DNA  was  isolated and 
bound to nitrocellulose using a slot blot apparatus (Schleicher & Schuell, 
Inc.,  Keene,  NH),  200  #g/well.  The  filters were  hybridized with  32p. 
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sis of RNA (15 ug/lane)  iso- 
lated  from ROS  17/2.8 cells 
(.4) and  neonatal  rat calvaria 
(B) cultured  in medium with 
or without  10 nM steroid for 
24 h. Lanes 1-3 were hybrid- 
ized with a BSP eDNA probe 
and lanes 4-6 were hybridized 
with  an  OPN  eDNA probe. 
(Lanes I and 4) Controls with- 
out  steroid;  (lanes  2  and  5) 
dexamethasone treated; (lanes 
3 and 6) vit D3 treated. 
labeled RNA and washed using the same conditions as described above for 
hybridization with BSP eDNA in RNA transfer blot analysis. 
Results 
We determined the effects of dexamethasone and vit D3 on 
the steady-state levels ofBSP mRNA in cultured neonatal rat 
calvaria and in  the rat osteosarcoma cell line  ROS  17/2.8 
(Fig.  1).  BSP mRNA levels increased threefold in calvaria 
tissue after exposure to dexamethasone for 24 h. In contrast, 
treatment with  vit D3  reduced  the  amount to one third of 
that in control without steroid. Similar effects of the steroids 
were seen in ROS  17/2.8  cells.  Without dexamethasone or 
with vit D3 no BSP mRNA was detected.  Dexamethasone 
increased the amounts of BSP mRNA to detectable levels in 
cultured osteosarcoma cells. In control experiments an iden- 
tical set of filters were hybridized with an OPN eDNA probe. 
Vit D3 increased the steady-state level of OPN mRNA about 
Figure 2. Time course of BSP mRNA increase in ROS 17/2.8 cells 
cultured  in  the  presence  of  10  nM  dexamethasone.  RNA  (15 
/~g/lane) was separated on an agarose gel, transferred to nitrocellu- 
lose, and hybridized with a BSP eDNA probe (top) and an OPN 
eDNA probe (bottom). (Lane 1 ) Control without dexamethasone; 
(lanes 2-5) cells exposed to dexamethasone for 3, 6, 12, and 24 h 
(lane 6) cells cultured in medium containing both dexamethasone 
(10 nM) and vit D3 (10 nM) for 24 h. 
fivefold in both calvaria and ROS  17/2.8  cells.  This agrees 
with previous results  reported by Yoon et al.  (15).  These 
authors also observed a reduction in OPN mRNA after treat- 
ment with dexamethasone. In the present set of experiments, 
however, we did not observe significantly decreased amounts 
of OPN mRNA after dexamethasone treatment. This may be 
due to a shorter dexamethasone exposure time of 24 h used 
by us as compared with 72 h used by Yoon et al. The amount 
of  BSP  mRNA  increased  with  time  in  dexamethasone- 
stimulated ROS 17/2.8 cells (Fig. 2), although the amount of 
BSP mRNA fluctuated with time in some experiments. The 
amounts of BSP mRNA were,  however,  always above the 
amount in untreated cells.  The reason for this variation in 
BSP mRNA levels is unknown. No BSP mRNA was detected 
when dexamethasone and vit D3 were added simultaneously 
to the osteosarcoma cells.  Apparently, the vit D3 suppres- 
sion  of the  BSP  mRNA  steady-state  level  overrides  the 
stimulatory effect of dexamethasone (Fig.  2). 
To determine if the increase of BSP mRNA was due to an 
increased  stability  and  half-life of mRNA  we  studied  its 
degradation  in  calvaria tissue  cultures  (Fig.  3).  Calvaria 
were kept in culture medium with or without dexamethasone 
for 24 h. After addition of DRB, a potent inhibitor of RNA 
synthesis (16), the rate of decreasing BSP mRNA was deter- 
mined. The half-life of BSP mRNA was found to be 4-5 h 
and was not affected by added dexamethasone. This result in- 
dicated that the regulation of BSP mRNA by dexamethasone 
is at the transcriptional level. A corresponding half-life of 6 h 
was determined when the same filter was hybridized with the 
OPN eDNA probe (data not shown). 
To provide further  support  for the  assumption that  the 
dexamethasone regulation is at the transcriptional level, we 
determined the amount of BSP mRNA synthesized by ROS 
17/2.8  cells with or without dexamethasone in the culture 
medium  (Fig.  4).  Radiolabeled  RNA  was  synthesized  in 
vitro in isolated nuclei and hybridized to filters carrying the 
single-stranded  M13  vector with  BSP or OPN  eDNA,  in 
sense or antisense orientation. Labeled RNA from nuclei of 
dexamethasone exposed cells hybridized to single-stranded 
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varia were cultured in medium with (o) or without 
(o) 10 nM dexametha~ne for 24 h. DRB was added 
to a final concentration of 100 nM. RNA was isolated 
after 5 and 10 h and subjected to transfer blot analysis 
with BSP cDNA as a  probe.  The  amount  of BSP 
mRNA before addition of DRB was set to 100%.  The 
blots used for densitometric scanning are shown in- 
serted. 
BSP cDNA in the antisense but not in the sense orientation. 
No hybridization with  BSP  was  seen  with RNA  from un- 
treated nuclei. The control indicates that similar amounts of 
OPN mRNA were synthesized with and without dexametha- 
sone. This nuclear run on experiment shows that dexametha- 
sone increases the transcriptional rate ofBSP mRNA. A sep- 
arate experiment was set up with ROS  17/2.8 cells to study 
the role of active protein synthesis in the increased transcrip- 
tion of BSP mRNA upon dexamethasone treatment.  Thus, 
cycloheximide when added simultaneously with the steroid 
abolished its effect on the BSP mRNA synthesis (Fig. 5). 
Discussion 
The  physiological significance of glucocorticoids in  bone 
homeostasis is unclear but the long-term therapeutic effect 
on patients is a decrease in bone mass. In model systems of 
in vitro bone formation, however, dexamethasone has been 
demonstrated  to  promote  the  formation of calcified bone 
nodules by primary cells isolated from rat calvaria (1).  This 
has been proposed to be due to a  stimulatory effect of dexa- 
methasone on the maturation of determined osteoprogenitor 
cells. It has also been suggested that the decrease in bone 
Figure 4. Nuclear transcription 
assay of nuclei isolated from 
ROS 17/2.8 cells cultured with- 
out (A) or with (B) 10 nM dex- 
amethasone for 24  h.  32p-la- 
beled RNA transcribed in vitro 
was hybridized with nitrocel- 
lulose filters carrying single- 
stranded MI3 vector with BSP 
or  OPN  cDNA  in  antisense 
(-) or sense (+) orientation. 
Figure  5.  Effect of cyclo- 
heximide on the induction 
of BSP  mRNA  by  dexa- 
methasone.  ROS  17/2.8 
cells were cultured for 10 h 
in medium (lane 1)  with- 
out additive, (lane 2) con- 
mining 10 nM dexametha- 
sone,  (lane 3)  containing 
5  ×  10  -5 M cycloheximide, 
or (lane 4)  containing  10 
nM dexamethasone plus 5  x  10-  5 M  cycloheximide. Total RNA 
was isolated from the cells and 15 #g was analyzed in transfer blot 
analysis with BSP (top) or OPN (bottom)  as probes. 
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apy follows from a depletion of  the reserves of  preosteoblasts 
and consequently a decrease in the number of bone mineral- 
producing os~oblasts (13). In this context it is relevant to 
note that the ROS 17/2.8 cell line attains a more osteoblastic 
phenotype in the presence of dexamethasone (14). The glu- 
cocorticoid causes the osteosarcoma cells to increase their 
expression of alkaline phosphatase, a key enzyme in the for- 
mation of hydroxyapatite. Interestingly, the ROS 17/2.8 cells 
when cultured with dexamethasone grow to a lower density 
and are morphologically different from cells in the absence 
of dexamethasone (14). The more adherent and flattened 
morphology induced by the corticosteroid may be a result of 
increased synthesis of BSP, which promotes attachment and 
spreading of ROS  17/2.8 cells. 
The exact mechanism of  dexamethasone action on the tran- 
scription of BSP mRNA is unclear. The comparatively long 
time needed to reach maximum levels ofBSP mRNA in ROS 
17/2.8 cells indicates that it does not involve the classical 
binding to enhancer elements in the BSP gene of the gluco- 
corticoid hormone-glucocorticoid receptor complex.  Fur- 
thermore, we have observed that the increase in BSP mRNA 
requires active protein synthesis, since cycloheximide pre- 
vented the effect. No change in the morphology of the cells 
was observed during the incubation period, indicating that 
the abolished dexamethasone effect was not due to acute tox- 
icity of cycloheximide. Cycloheximide treatment gave some 
reduction of the expression of OPN mRNA, probably a re- 
sult of the decreasing number of viable cells during the ex- 
periment. The loss of expression of BSP mRNA during these 
conditions, however, indicates a more pronounced effect on 
the expression of this protein. Thus, the effect of dexametha- 
sone on the steady-state level of BSP mRNA is most likely 
indirect and may involve changes in the phenotype of the os- 
teosarcoma cells. A corresponding effect on bone tissue, e.g., 
calvaria, could involve maturation of preosteoblasts. In sup- 
port, the synthesis of BSP mRNA in both calvaria and ROS 
17/2.8 cells was inhibited by vit D3,  which has been pro- 
posed to inhibit the maturation of osteoblasts from progeni- 
tor cells (Ishida, H., D. G. Bellows, J. E. Aubin, and J. N. M. 
Heersche, Calcif.  lissue Int.,  Suppl. 42, Abstr.  19).  This 
effect is also in accordance with the induced mobilization of 
calcium into the circulation by vit D3. 
The effects of steroids on the synthesis ofBSP mRNA sug- 
gest that the protein is a product of mature osteoblasts pro- 
ducing bone matrix. The function of the protein is unknown 
but it may be associated with key functions of bone-produc- 
ing cells, such as regulation of hydroxyapatite  crystal nuclea- 
tion and growth. 
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